Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 209

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies

Wang, Lin, Alammar, Nuha, Singh, Rajdeep, Nanavati, Julie, Song, Yiran, Chaudhary, Rahul, Mullin, Gerard E.·2020·Journal of the Academy of Nutrition and Dietetics
DOI 10.1016/j.jand.2019.05.015
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jand.2019.05.015

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 78

  1. El-Salhy, 2012, Irritable bowel syndrome: Diagnosis and pathogenesis, World J Gastroenterol, 18, 5151, 10.3748/wjg.v18.i37.5151 · DOI
  2. Simren, 2017, Update on Rome IV Criteria for colorectal disorders: Implications for clinical practice, Curr Gastroenterol Rep, 19, 15, 10.1007/s11894-017-0554-0 · DOI
  3. Makker, 2015, Genetic epidemiology of irritable bowel syndrome, World J Gastroenterol, 21, 11353, 10.3748/wjg.v21.i40.11353 · DOI
  4. Powell, 2017, The mucosal immune system: Master regulator of bidirectional gut-brain communications, Nat Rev Gastroenterol Hepatol, 14, 143, 10.1038/nrgastro.2016.191 · DOI · Paper page
  5. Pellissier, 2017, The place of stress and emotions in the irritable bowel syndrome, Vitam Hormon, 103, 327, 10.1016/bs.vh.2016.09.005 · DOI
  6. Deiteren, 2016, Irritable bowel syndrome and visceral hypersensitivity: Risk factors and pathophysiological mechanisms, Acta Gastroenterol Belg, 79, 29
  7. Quigley, 2005, Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: Biological markers or epiphenomenon, Gastroenterol Clin North Am, 34, 221, 10.1016/j.gtc.2005.02.010 · DOI
  8. Mullin, 2014, Irritable bowel syndrome: Contemporary nutrition management strategies, JPEN, 38, 781, 10.1177/0148607114545329 · DOI
  9. Sundin, 2017, Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases, Psychosom Med, 79, 857, 10.1097/PSY.0000000000000470 · DOI
  10. Moloney, 2016, Stress and the microbiota-gut-brain axis in visceral parelevance to irritable bowel syndrome, CNS Neurosci Ther, 22, 102, 10.1111/cns.12490 · DOI · Paper page
  11. Gonzalez-Castro, 2017, Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome, J Gastroenterol Hepatol, 32, 53, 10.1111/jgh.13417 · DOI
  12. Rea, 2017, The role of the gastrointestinal microbiota in visceral pain, Handb Exp Pharmacol, 239, 269, 10.1007/164_2016_115 · DOI
  13. Fukui, 2016, Increased intestinal permeability and decreased barrier function: Does it really influence the risk of inflammation?, Inflamm Intest Dis, 1, 135, 10.1159/000447252 · DOI · Paper page
  14. Ohman, 2010, Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions, Nat Rev Gastroenterol Hepatol, 7, 163, 10.1038/nrgastro.2010.4 · DOI · Paper page
  15. Moser, 2018, Intestinal microbiome-gut-brain axis and irritable bowel syndrome, Wien Med Wochenschr, 168, 62, 10.1007/s10354-017-0592-0 · DOI
  16. Halvorson, 2006, Postinfectious irritable bowel syndrome—A meta-analysis, Am J Gastroenterol, 101, 1894, 10.1111/j.1572-0241.2006.00654.x · DOI · Paper page
  17. Li, 2016, Rifaximin for irritable bowel syndrome: A meta-analysis of randomized placebo-controlled trials, Medicine (Baltimore), 95, 10.1097/MD.0000000000002534 · DOI
  18. Zhang, 2016, Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: A meta-analysis, BMC Gastroenterol, 16, 62, 10.1186/s12876-016-0470-z · DOI
  19. Valentin, 2017, Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome, Physiol Rep, 5, 10.14814/phy2.13170 · DOI
  20. El-Salhy, 2018, Fecal microbiota transplantation for managing irritable bowel syndrome, Expert Rev Gastroenterol Hepatol, 12, 439, 10.1080/17474124.2018.1447380 · DOI
  21. Jernberg, 2007, Long-term ecological impacts of antibiotic administration on the human intestinal microbiota, ISME J, 1, 56, 10.1038/ismej.2007.3 · DOI · Paper page
  22. Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration, PLoS Med, 6, 10.1371/journal.pmed.1000100 · DOI · Paper page
  23. Stroup, 2000, Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  24. DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  25. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  26. Ioannidis, 2007, Uncertainty in heterogeneity estimates in meta-analyses, BMJ, 335, 914, 10.1136/bmj.39343.408449.80 · DOI · Paper page
  27. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  28. Kicinski, 2015, Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews, Stat Med, 34, 2781, 10.1002/sim.6525 · DOI
  29. Zhang, 2008, Significance of intestinal tract normal bacteria flora quantitative analysis of IBS sufferers, Chin Med Guides, 5, 94
  30. Zhang, 2009, Analysis of targeted gut microbiota inpatients with irritable bowel syndrome using 16 s rDNA qPCR, Shandong Med J, 49, 51
  31. Durban, 2012, Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome, Environ Microbiol Rep, 4, 242, 10.1111/j.1758-2229.2012.00327.x · DOI
  32. Hua, 2014, Changes of the intestinal microflora in children with irritable bowel syndrome by SYBR green 1 real time fluorescent quantitative PCR method, Med Pharm J Chin Peoples Liberation Army, 26, 93
  33. Sheikh Sajjadieh, 2012, Dysbiosis in Ukrainian children with irritable bowel syndrome affected by natural radiation, Iran J Pediatr, 22, 364
  34. Carroll, 2011, Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome, Am J Physiol Gastrointest Liver Physiol, 301, G799, 10.1152/ajpgi.00154.2011 · DOI · Paper page
  35. Chassard, 2012, Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome, Aliment Pharmacol Ther, 35, 828, 10.1111/j.1365-2036.2012.05007.x · DOI
  36. Cui, 2012, Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study, Int J Clin Exp Med, 5, 238
  37. Mättö, 2005, Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome—A longitudinal study in IBS and control subjects, FEMS Immunol Med Microbiol, 43, 213, 10.1016/j.femsim.2004.08.009 · DOI · Paper page
  38. Li, 2014, Analysis of patients with intestinal target bacteria diarrhea type irritable bowel syndrome, Acta Univ, 49, 633
  39. Chen, 2014, Study on the intestinal flora status of patients with different subtypes of irritable bowel syndrome, Jiangxi Med J, 49, 1459
  40. Wang, 2015, Changes of intestinal flora and mast cells in patients with irritable bowel syndrome and ulcerative colitis, Guangdong Med J, 36, 756
  41. Hu, 2012, Alteration and significance ofintestinal microbiota in patients with irritable bowel syndrome, Univ Med Anhui, 47, 86
  42. Zhuang, 2005, Study on the microecologicalchanges and curetive effects of irritable bowel syndrome by Chinese drug “Shenqu, Chin J Microecol, 17, 41
  43. Lopetuso, 2018, Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: Time for microbial marker of gastrointestinal disorders, Dig Dis, 36, 56, 10.1159/000477205 · DOI
  44. Zhuang, 2017, Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis, J Gastroenterol Hepatol, 32, 28, 10.1111/jgh.13471 · DOI
  45. Yu, 2004, Control study on the microecology in irritable bowel syndrome, Chin J Digest, 24, 427
  46. Zhang, 1999, Intestinal flora changesin patients with irritable bowel syndrome after ingestion of Clostridium butyicum preparation, Chin J Microecol, 11, 164
  47. Li, 2003, Analysis of the gut microbiota and treatment of 63 cases of patients with irritable bowel syndrome, J Chin Physician, S1, 92
  48. Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344 · DOI · Paper page
  49. Shukla, 2015, Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: An evidence of dysbiosis, Digest Dis Sci, 60, 2953, 10.1007/s10620-015-3607-y · DOI
  50. Rinttila, 2004, Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR, J Appl Microbiol, 97, 1166, 10.1111/j.1365-2672.2004.02409.x · DOI · Paper page
  51. Gerritzen, 2011, Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay, Clin Lab, 57, 993
  52. Kontopantelis, 2013, A re-analysis of the Cochrane Library data: The dangers of unobserved heterogeneity in meta-analyses, PLoS One, 8, 10.1371/journal.pone.0069930 · DOI · Paper page
  53. Saulnier, 2011, Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome, Gastroenterology, 141, 1782, 10.1053/j.gastro.2011.06.072 · DOI · Paper page
  54. Rajilic-Stojanovic, 2011, Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome, Gastroenterology, 141, 1792, 10.1053/j.gastro.2011.07.043 · DOI · Paper page
  55. Jalanka-Tuovinen, 2014, Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome, Gut, 63, 1737, 10.1136/gutjnl-2013-305994 · DOI · Paper page
  56. Rangel, 2015, The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects, Aliment Pharmacol Ther, 42, 1211, 10.1111/apt.13399 · DOI
  57. Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591 · DOI · Paper page
  58. Maharshak, 2018, Fecal and mucosa-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome, Digest Dis Sci, 63, 1890, 10.1007/s10620-018-5086-4 · DOI
  59. Keita, 2018, Mucosal permeability and mast cells as targets for functional gastrointestinal disorders, Curr Opin Pharmacol, 43, 66, 10.1016/j.coph.2018.08.011 · DOI
  60. Damodharan, 2015, In vitro probiotic characterization of Lactobacillus strains from fermented radish and their anti-adherence activity against enteric pathogens, Can J Microbiol, 61, 837, 10.1139/cjm-2015-0311 · DOI
  61. Pusceddu, 2018, Visceral pain: Gut microbiota, a new hope?, J Biomed Sci, 25, 73, 10.1186/s12929-018-0476-7 · DOI
  62. Ringel-Kulka, 2014, Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain—A randomised clinical study, Aliment Pharmacol Ther, 40, 200, 10.1111/apt.12800 · DOI
  63. de Weerth, 2017, Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis, Neurosci Biobehav Rev, 83, 458, 10.1016/j.neubiorev.2017.09.016 · DOI
  64. Yousefi, 2019, Probiotics importance and their immunomodulatory properties, J Cell Physiol, 234, 8008, 10.1002/jcp.27559 · DOI
  65. Cao, 2018, Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells, Saudi J Gastroenterol, 24, 59, 10.4103/sjg.SJG_333_17 · DOI
  66. Schumann, 2018, Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis, Nutrition, 45, 24, 10.1016/j.nut.2017.07.004 · DOI
  67. Staudacher, 2014, Mechanisms and efficacy of dietary FODMAP restriction in IBS, Nat Rev Gastroenterol Hepatol, 11, 256, 10.1038/nrgastro.2013.259 · DOI
  68. Staudacher, 2012, Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome, J Nutr, 142, 1510
  69. McIntosh, 2017, FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial, Gut, 66, 1241, 10.1136/gutjnl-2015-311339 · DOI · Paper page
  70. Chumpitazi, 2015, Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome, Aliment Pharmacol Ther, 42, 418, 10.1111/apt.13286 · DOI · Paper page
  71. Parkes, 2012, Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome, Neurogastroenterol Motil, 24, 31, 10.1111/j.1365-2982.2011.01803.x · DOI · Paper page
  72. Russell, 2011, Metabolic activities and probiotic potential of bifidobacteria, Int J Food Microbiol, 149, 88, 10.1016/j.ijfoodmicro.2011.06.003 · DOI · Paper page
  73. Sloan, 2018, A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects, PLoS One, 13, 10.1371/journal.pone.0201410 · DOI
  74. Tuohy, 2012, Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber, J Agric Food Chem, 60, 8776, 10.1021/jf2053959 · DOI · Paper page
  75. Connolly, 2012, Wholegrain oat-based cereals have prebiotic potential and low glycaemic index, Br J Nutr, 108, 2198, 10.1017/S0007114512000281 · DOI
  76. Staudacher, 2016, Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: Probiotics, prebiotics and the low FODMAP diet, Proc Nutr Soc, 75, 306, 10.1017/S0029665116000021 · DOI
  77. Valeur, 2018, Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome, Digest Dis Sci, 63, 429, 10.1007/s10620-017-4893-3 · DOI
  78. Bennet, 2018, Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs, Gut, 67, 872, 10.1136/gutjnl-2016-313128 · DOI · Paper page

Cited by

Metadata

Authors
Wang, L., Alammar, N., Singh, R., Nanavati, J., Song, Y., Chaudhary, R., & Mullin, G. E.
Venue
Journal of the Academy of Nutrition and Dietetics
Publisher
Elsevier BV
Published
2020-04
Volume
120
Issue
4
Pages
565-586
ISSN
2212-2672
DOI
10.1016/j.jand.2019.05.015
Cited by
209
References
27
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
School of Medicine, Johns Hopkins University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.